Coronary disease risk assessment in men: Comparison between ASCVD Risk versus Framingham

详细信息    查看全文

• 作者：Natá ; lia Maria Maciel Guerra-Silva^a ; ^b ; ^{natyguerra@uenp.edu.br} ; Fernanda Sene Santucci^b ; Ricardo Castanho Moreira^b ; Cristiano Massao Tashima^b ; Simone Cristina Castanho Sabaini de Melo^b ; Leonardo Regis Leira Pereira^c ; Debora de Mello Gonç ; ales Sant'Ana^a
• 关键词：Men's health ; Hypertension ; Heart diseases ; Early diagnosis
• 刊名：International Journal of Cardiology
• 出版年：2017
• 出版时间：1 February 2017
• 年：2017
• 卷：228
• 期：Complete
• 页码：481-487
• 全文大小：255 K
• 卷排序：228

文摘

This study evaluated the risk of men developing coronary heart disease and its determinant variables, comparing these results through two validated coronary risk scales.MethodsA cross sectional epidemiological analytical study in which data were collected by spontaneous demand, through a semi-structured questionnaire, clinical examination, and blood collection. The Chi-square test, logistic regression and Kappa for statistical analysis were performed.ResultsThe study included 637 men. Age was a determining factor (p < 0.05) in blood pressure (BP) changes, central obesity, BMI, glycemia, total cholesterol, LDL and triglycerides. From this group of 637, 252 presented BP above the recommended values. It was found that 34.54% of men had high total cholesterol, 19.94% had high LDL, 46.78% presented HDL below normal values and 36.42% had elevated triglycerides. Metabolic syndrome was found in 24.96% of the men. With the Framingham scale, 637 men were evaluated, 12.56% were at intermediate-risk and 5.49% elevated risk, while on the ASCVD Risk scale 553 men were evaluated, and 7.05% had moderate risk and none had high coronary risk. In this study, 50.43% of men still had no previous diagnosis for any disease that increases the risk factors.ConclusionsThe determinant clinical variables were age, blood pressure, smoking, central obesity, race and education. The Framingham scale allowed the assessment of cardiac risk of all men in the study, with no age restriction or cholesterol value, so in population studies it shows advantages over the ASCVD Risk due to its comprehensive feature of including all individuals.